{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:22:36Z","timestamp":1790680956978,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Council at Odense University Hospital","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"crossref","award":["14-R97-A5266"],"award-info":[{"award-number":["14-R97-A5266"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173362","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T18:40:20Z","timestamp":1489084820000},"page":"e0173362","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity"],"prefix":"10.1371","volume":"12","author":[{"given":"Michael","family":"Stenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Behr-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus B.","family":"Gr\u00f8nnemose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Emil","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne K.","family":"Klitgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00f8rn","family":"Kolmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes S.","family":"Lindholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/14787210.5.2.305","article-title":"Prevention and treatment of aortic graft infection","volume":"5","author":"FF Mussa","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153857440604000101","article-title":"Aortic graft infection: update on management and treatment options","volume":"40","author":"GB Perera","year":"2006","journal-title":"Vasc Endovascular Surg"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/153857440403800110","article-title":"Management of infected aortic prosthetic grafts","volume":"38","author":"TW Swain 3rd","year":"2004","journal-title":"Vasc Endovascular Surg"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0895-7967(02)70026-4","article-title":"Antibiotics-why so many and when should we use them?","volume":"15","author":"DF Bandyk","year":"2002","journal-title":"Semin Vasc Surg"},{"issue":"Suppl 2","key":"ref5","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1111\/j.1444-0903.2005.00981.x","article-title":"Diagnosis and management of staphylococcal infections of vascular grafts and stents","volume":"35","author":"ST Chambers","year":"2005","journal-title":"Intern Med J"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jvs.2006.02.053","article-title":"A systematic review and meta-analysis of treatments for aortic graft infection","volume":"44","author":"S O'Connor","year":"2006","journal-title":"J Vasc Surg"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semvascsurg.2011.10.014","article-title":"Conservative treatment of aortic graft infection","volume":"24","author":"PF Lawrence","year":"2011","journal-title":"Semin Vasc Surg"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0163-4453(00)80014-6","article-title":"Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts","volume":"40","author":"D Roy","year":"2000","journal-title":"J Infect"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjsurg.2009.05.018","article-title":"Conservative treatment of vascular prosthetic graft infection is associated with high mortality","volume":"200","author":"BR Saleem","year":"2010","journal-title":"Am J Surg"},{"key":"ref10","first-page":"33","article-title":"The case against the conservative nonresectional management of infected prosthetic grafts","volume":"29","author":"RA Yeager","year":"1996","journal-title":"Adv Surg"},{"issue":"14","key":"ref11","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1128\/JB.186.14.4486-4491.2004","article-title":"Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model","volume":"186","author":"CA Fux","year":"2004","journal-title":"J Bacteriol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"N Hoiby","year":"2010","journal-title":"International journal of antimicrobial agents"},{"issue":"6","key":"ref13","first-page":"1215","article-title":"Reversal of methicillin resistance in Staphylococcus aureus by thioridazine","volume":"62","author":"JK Klitgaard","year":"2008","journal-title":"JAntimicrobChemother"},{"issue":"3","key":"ref14","first-page":"250","article-title":"Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro","volume":"22","author":"MM Kristiansen","year":"2003","journal-title":"IntJAntimicrobAgents"},{"issue":"3","key":"ref15","first-page":"361","article-title":"Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump","volume":"20","author":"MM Kristiansen","year":"2006","journal-title":"In Vivo"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.resmic.2012.10.007","article-title":"Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression","volume":"164","author":"MO Poulsen","year":"2013","journal-title":"Research in microbiology"},{"key":"ref17","article-title":"Combination of thioridazine and dicloxacillin combats Methicillin-resistant Staphylococcus aureus infections in Caenorhabditis elegans","author":"MO Poulsen","year":"2014","journal-title":"Journal of medical microbiology"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"e0135571","DOI":"10.1371\/journal.pone.0135571","article-title":"Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model","volume":"10","author":"M Stenger","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"ref19","first-page":"33","article-title":"Effect of thioridazine on experimental cutaneous staphylococcal infections","volume":"28","author":"BL Hahn","year":"2014","journal-title":"In Vivo"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1574-6968.2011.02255.x","article-title":"Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus","volume":"318","author":"M Bonde","year":"2011","journal-title":"FEMS microbiology letters"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"e64518","DOI":"10.1371\/journal.pone.0064518","article-title":"Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300","volume":"8","author":"M Thorsing","year":"2013","journal-title":"PloS one"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1128\/AEM.01310-08","article-title":"Inactivation of efflux pumps abolishes bacterial biofilm formation","volume":"74","author":"M Kvist","year":"2008","journal-title":"Applied and environmental microbiology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2016.09.018","article-title":"Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection. Journal of controlled release: official journal of the","volume":"241","author":"M Stenger","year":"2016","journal-title":"Controlled Release Society"},{"key":"ref24","unstructured":"Dicillin\u00ae h\u00e5rde kapsler 250 mg og 500 mg Sandoz A\/S: Danish Medicines Agency; 2015. Available from: http:\/\/www.indlaegssedler.dk\/indlaegssedler\/indlaegsseddel\/11004<\/ext-link>."},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejvs.2007.07.005","article-title":"Laparoscopic diagnosis and treatment of aortic vascular prosthetic graft infections in a porcine model","volume":"35","author":"H Gao","year":"2008","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejvs.2009.11.023","article-title":"Prevention of primary vascular graft infection with silver-coated polyester graft in a porcine model","volume":"39","author":"H Gao","year":"2010","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejvs.2012.02.011","article-title":"Rifampicin-soaked silver polyester versus expanded polytetrafluoro-ethylene grafts for in situ replacement of infected grafts in a porcine randomised controlled trial","volume":"43","author":"H Gao","year":"2012","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery"},{"key":"ref28","article-title":"Dukes' Physiology of Domestic Animals","author":"D Robertshaw","year":"2004"},{"key":"ref29","unstructured":"Medscape. thioridazine (Rx)\u2014Mellaril 2015 [cited 2015 27th of July]. Available from: http:\/\/reference.medscape.com\/drug\/thioridazine-342987-0<\/ext-link>."},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"e57493","DOI":"10.1371\/journal.pone.0057493","article-title":"A comparative analysis of in vitro and in vivo efficacies of the enantiomers of thioridazine and its racemate","volume":"8","author":"JB Christensen","year":"2013","journal-title":"PloS one"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijantimicag.2009.09.027","article-title":"Thioridazine protects the mouse from a virulent infection by Salmonella enterica serovar Typhimurium 74","volume":"35","author":"A Dasgupta","year":"2010","journal-title":"International journal of antimicrobial agents"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1699-0463.1988.tb00984.x","article-title":"Synergy between a non-neuroleptic thioxanthene stereo-isomer and penicillin in vivo","volume":"96","author":"JE Kristiansen","year":"1988","journal-title":"APMIS"},{"issue":"5","key":"ref33","first-page":"771","article-title":"The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis","volume":"21","author":"M Martins","year":"2007","journal-title":"In Vivo"},{"key":"ref34","first-page":"323","article-title":"The Minipig in Biomedical Research","author":"DD Harry","year":"2011"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/taap.1999.8688","article-title":"The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions","volume":"158","author":"WA Daniel","year":"1999","journal-title":"Toxicology and applied pharmacology"},{"issue":"6","key":"ref36","first-page":"787","article-title":"Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study","volume":"18","author":"M Martins","year":"2004","journal-title":"In Vivo"},{"issue":"2\u20133","key":"ref37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0379-0738(94)90227-5","article-title":"Thioridazine enantiomers in human tissues","volume":"64","author":"SA Jortani","year":"1994","journal-title":"Forensic Sci Int"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jama.2015.6669","article-title":"Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists","volume":"314","author":"A Pottegard","year":"2015","journal-title":"Jama"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1124\/dmd.108.020701","article-title":"A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine","volume":"36","author":"K Yasuda","year":"2008","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/dmd.105.006445","article-title":"Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine","volume":"34","author":"J Wojcikowski","year":"2006","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejps.2011.03.008","article-title":"Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans","volume":"43","author":"HA Thorn","year":"2011","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0022-3565(25)21884-5","article-title":"Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors","volume":"228","author":"DM Niedzwiecki","year":"1984","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2014.11.015","article-title":"Differential effects of thioridazine enantiomers on action potential duration in rabbit papillary muscle","volume":"747","author":"AS Jensen","year":"2015","journal-title":"European journal of pharmacology"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"L Ejim","year":"2011","journal-title":"Nature chemical biology"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1021\/jm400262a","article-title":"Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance","volume":"56","author":"S Sabatini","year":"2013","journal-title":"Journal of medicinal chemistry"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ja.2008.102","article-title":"Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities","volume":"61","author":"A Fukumoto","year":"2008","journal-title":"J Antibiot (Tokyo)"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"e48981","DOI":"10.1371\/journal.pone.0048981","article-title":"The nonantibiotic small molecule cyslabdan enhances the potency of beta-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis","volume":"7","author":"N Koyama","year":"2012","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:47:05Z","timestamp":1750085225000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173362"}},"subtitle":[],"editor":[{"given":"Tom","family":"Coenye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173362","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]}}}